Britain has greenlit the country's free healthcare system to use a CRISPR gene-editing therapy for sickle cell anaemia that it is hoped will be a complete cure for the genetic disorder.
Open link in next tab
UK medicines regulator approves gene therapy for two blood disorders
https://www.theguardian.com/society/2023/nov/16/uk-medicines-regulator-approves-casgevy-gene-therapy-for-two-blood-disorders-sickle-cell
MHRA authorises uses of Casgevy as a potential cure for sickle cell disease and beta thalassemia